ReP USP - Resultado da busca

Artigo de periodico
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes (2019)
Roe, Matthew T; Li, Qian H; Bhatt, Deepak L; Bittner, Vera A; Diaz, Rafael; Goodman, Shaun G; Harrington, Robert A; Jukema, J. Wouter; Lopez-jaramillo, Patricio; Nicolau, José Carlos
Source: Circulation. Unidade: FM
Subjects: DIRETRIZES PARA A PRÁTICA CLÍNICA, ISQUEMIA MIOCÁRDICA, DISLIPIDEMIAS, ENZIMAS PROTEOLÍTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROE, Matthew T et al. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes. Circulation, v. 140, n. 19, p. 1578-1589, 2019Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.119.042551. Acesso em: 01 nov. 2024.
APA
Roe, M. T., Li, Q. H., Bhatt, D. L., Bittner, V. A., Diaz, R., Goodman, S. G., et al. (2019). Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes. Circulation, 140( 19), 1578-1589. doi:10.1161/CIRCULATIONAHA.119.042551
NLM
Roe MT, Li QH, Bhatt DL, Bittner VA, Diaz R, Goodman SG, Harrington RA, Jukema JW, Lopez-jaramillo P, Nicolau JC. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes [Internet]. Circulation. 2019 ; 140( 19): 1578-1589.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.119.042551
Vancouver
Roe MT, Li QH, Bhatt DL, Bittner VA, Diaz R, Goodman SG, Harrington RA, Jukema JW, Lopez-jaramillo P, Nicolau JC. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes [Internet]. Circulation. 2019 ; 140( 19): 1578-1589.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.119.042551
Artigo de periodico
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial (2019)
Jukema, J. Wouter; Szarek, Michael; Zijlstra, Laurien E; Silva, H. Asita de; Bhatt, Deepak L; Bittner, Vera A; Diaz, Rafael; Edelberg, Jay M; Goodman, Shaun G; Nicolau, José Carlos
Source: Journal of the american college of cardiology. Unidade: FM
Subjects: SÍNDROME CORONARIANA AGUDA, ARTERIOSCLEROSE, ANTICORPOS MONOCLONAIS, DISLIPIDEMIAS, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JUKEMA, J. Wouter et al. Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial. Journal of the american college of cardiology, v. 74, n. 9, p. 1167-1176, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2019.03.013. Acesso em: 01 nov. 2024.
APA
Jukema, J. W., Szarek, M., Zijlstra, L. E., Silva, H. A. de, Bhatt, D. L., Bittner, V. A., et al. (2019). Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial. Journal of the american college of cardiology, 74( 9), 1167-1176. doi:10.1016/j.jacc.2019.03.013
NLM
Jukema JW, Szarek M, Zijlstra LE, Silva HA de, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Nicolau JC. Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial [Internet]. Journal of the american college of cardiology. 2019 ; 74( 9): 1167-1176.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jacc.2019.03.013
Vancouver
Jukema JW, Szarek M, Zijlstra LE, Silva HA de, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Nicolau JC. Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial [Internet]. Journal of the american college of cardiology. 2019 ; 74( 9): 1167-1176.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jacc.2019.03.013
Artigo de periodico
Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation (2017)
Christophersen, Ingrid E.; Rienstra, Michiel; Roselli, Carolina; Yin, Xiaoyan; Geelhoed, Bastiaan; Barnard, John; Lin, Honghuang; Arking, Dan E.; Smith, Albert V.; Albert, Christine M.; Chaffin, Mark; Tucker, Nathan R.; Li, Molong; Klarin, Derek; Bihlmeyer, Nathan A.; Low, Siew-Kee; Weeke, Peter E.; Nurasyid, Martina Müller; Smith, J. Gustav; Brody, Jennifer A.; Niemeijer, Maartje N; Dörr, Marcus; Trompet, Stella; Huffman, Jennifer; Gustafsson, Stefan; Schurmann, Claudia; Kleber, Marcus E.; Lyytikäinen, Leo-Pekka; Seppälä, Ilkka; Malik, Rainer; Horimoto, Andrea R. V; Perez, Marco; Sinisalo, Juha; Aeschbacher, Stefanie; Theriault, Sébastien; Yao, Jie; Radmanesh, Farid; Teumer, Alexander; Choi, Seung Hoan; Weng, Lu-Chen; Clauss, Sebastian; Deo, Rajat; Rader, Daniel J; Shah, Svati H; Sun, Albert; Hopewell, Jemma C.; Debette, Stephanie; Chauhan, Ganesh; Yang, Qiong; Worral, Bradford B; Paré, Guillaume; Kamatani, Yoichiro; Hagemeijer, Yanick P; Verweij, Niek; Siland, Joylene E; Kubo, Michiaki; Smith, Jonathan D; Wagoner, David R. Van; Bis, Joshua C; Perz, Siegfried; Psaty, Bruce M; Ridker, Paul M; Magnani, Jared W; Harris, Tamara B; Launer, Lenore J; Shoemaker, M. Benjamin; Padmanabhan, Sandosh; Haessler, Jeffrey; Bartz, Traci M; Waldenberger, Melanie; Lichtner, Peter; Krieger, José Eduardo; Kähönen, Mika; Risch, Lorenz; Mansur, Alfredo José; Peters, Annette; Smith, Blair H; Lind, Lars; Scott, Stuart A; Lu, Yingchang; Bottinger, Erwin B; Hernesniemi, Jussi; Lindgren, Cecilia M; Wong, Jorge A; Huang, Jie; Eskola, Markku; Morris, Andrew P; Ford, Ian; Reiner, Alex P; Delgado, Graciela; Yen, Lin Y; Chen, Yii-Der Ida; Sandhu, Roopinder; Li, Man; Boerwinkle, Eric; Eisele, Lewin; Lannfelt, Lars; Rost, Natalia; Anderson, Christopher D; Taylor, Kent D; Campbell, Archie; Magnusson, Patrick K; Porteous, David; Hoking, Lynne J; Vlachopoulou, Efthymia; Pedersen, Nancy L; Nikus, Kjell; Melander, Marju Orho; Hamsten, Anders; Heeringa, Jan; Denny, Joshua C; Kriebel, Jennifer; Darbar, Dawood; Cheh, Christopher Newton; Shaffer,Christian; Macfarlane, Peter W; Heimbach, Stefanie Heilmann; Almgren, Peter; Huang, Paul L.; Sotoodehnia, Nona; Soliman, Elsayed Z; Uitterlinden, Andre G; Hofman, Albert; Franco, Oscar H; Völker, Uwe; Jöckel, Karl-Heinz; Sinner,Moritz F; Lin, Henry J; Guo, Xiuqing; Dichgans, Martin; Ingelsson, Erik; Kooperberg, Charles; Melander, Olle; Loos, Ruth J. F; Laurikka, Jari; Conen, David; Rosand, Jonathan; Harst, Pim van der; Lokki, Marja-Liisa; Kathiresan, Sekar; Pereira, Alexandre; Jukema, J. Wouter; Hayward, Caroline; Rotter, Jerome I; März, Winfried; Lehtimäki, Terho; Stricker, Bruno H; Chung, Mina K; Felix, Stephan B; Gudnason, Vilmundur; Alonso, Alvaro; Roden, Dan M; Kääb, Stefan; Chasman, Daniel I; Heckbert, Susan R; Benjamin, Emelia J; Tanaka, Toshihiro; Lunetta, Kathryn L; Lubitz, Steven A; Ellinor, Patrick T
Source: Nature Genetics. Unidade: FM
Subjects: FIBRILAÇÃO ATRIAL, METANÁLISE, DOENÇAS CARDIOVASCULARES, GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHRISTOPHERSEN, Ingrid E. et al. Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nature Genetics, v. 49, n. 6, p. 946-952, 2017Tradução . . Disponível em: https://doi.org/10.1038/ng.3843. Acesso em: 01 nov. 2024.
APA
Christophersen, I. E., Rienstra, M., Roselli, C., Yin, X., Geelhoed, B., Barnard, J., et al. (2017). Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nature Genetics, 49( 6), 946-952. doi:10.1038/ng.3843
NLM
Christophersen IE, Rienstra M, Roselli C, Yin X, Geelhoed B, Barnard J, Lin H, Arking DE, Smith AV, Albert CM, Chaffin M, Tucker NR, Li M, Klarin D, Bihlmeyer NA, Low S-K, Weeke PE, Nurasyid MM, Smith JG, Brody JA, Niemeijer MN, Dörr M, Trompet S, Huffman J, Gustafsson S, Schurmann C, Kleber ME, Lyytikäinen L-P, Seppälä I, Malik R, Horimoto ARV, Perez M, Sinisalo J, Aeschbacher S, Theriault S, Yao J, Radmanesh F, Teumer A, Choi SH, Weng L-C, Clauss S, Deo R, Rader DJ, Shah SH, Sun A, Hopewell JC, Debette S, Chauhan G, Yang Q, Worral BB, Paré G, Kamatani Y, Hagemeijer YP, Verweij N, Siland JE, Kubo M, Smith JD, Wagoner DRV, Bis JC, Perz S, Psaty BM, Ridker PM, Magnani JW, Harris TB, Launer LJ, Shoemaker MB, Padmanabhan S, Haessler J, Bartz TM, Waldenberger M, Lichtner P, Krieger JE, Kähönen M, Risch L, Mansur AJ, Peters A, Smith BH, Lind L, Scott SA, Lu Y, Bottinger EB, Hernesniemi J, Lindgren CM, Wong JA, Huang J, Eskola M, Morris AP, Ford I, Reiner AP, Delgado G, Yen LY, Chen Y-DI, Sandhu R, Li M, Boerwinkle E, Eisele L, Lannfelt L, Rost N, Anderson CD, Taylor KD, Campbell A, Magnusson PK, Porteous D, Hoking LJ, Vlachopoulou E, Pedersen NL, Nikus K, Melander MO, Hamsten A, Heeringa J, Denny JC, Kriebel J, Darbar D, Cheh CN, Shaffer C, Macfarlane PW, Heimbach SH, Almgren P, Huang PL, Sotoodehnia N, Soliman EZ, Uitterlinden AG, Hofman A, Franco OH, Völker U, Jöckel K-H, Sinner MF, Lin HJ, Guo X, Dichgans M, Ingelsson E, Kooperberg C, Melander O, Loos RJF, Laurikka J, Conen D, Rosand J, Harst P van der, Lokki M-L, Kathiresan S, Pereira A, Jukema JW, Hayward C, Rotter JI, März W, Lehtimäki T, Stricker BH, Chung MK, Felix SB, Gudnason V, Alonso A, Roden DM, Kääb S, Chasman DI, Heckbert SR, Benjamin EJ, Tanaka T, Lunetta KL, Lubitz SA, Ellinor PT. Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation [Internet]. Nature Genetics. 2017 ; 49( 6): 946-952.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1038/ng.3843
Vancouver
Christophersen IE, Rienstra M, Roselli C, Yin X, Geelhoed B, Barnard J, Lin H, Arking DE, Smith AV, Albert CM, Chaffin M, Tucker NR, Li M, Klarin D, Bihlmeyer NA, Low S-K, Weeke PE, Nurasyid MM, Smith JG, Brody JA, Niemeijer MN, Dörr M, Trompet S, Huffman J, Gustafsson S, Schurmann C, Kleber ME, Lyytikäinen L-P, Seppälä I, Malik R, Horimoto ARV, Perez M, Sinisalo J, Aeschbacher S, Theriault S, Yao J, Radmanesh F, Teumer A, Choi SH, Weng L-C, Clauss S, Deo R, Rader DJ, Shah SH, Sun A, Hopewell JC, Debette S, Chauhan G, Yang Q, Worral BB, Paré G, Kamatani Y, Hagemeijer YP, Verweij N, Siland JE, Kubo M, Smith JD, Wagoner DRV, Bis JC, Perz S, Psaty BM, Ridker PM, Magnani JW, Harris TB, Launer LJ, Shoemaker MB, Padmanabhan S, Haessler J, Bartz TM, Waldenberger M, Lichtner P, Krieger JE, Kähönen M, Risch L, Mansur AJ, Peters A, Smith BH, Lind L, Scott SA, Lu Y, Bottinger EB, Hernesniemi J, Lindgren CM, Wong JA, Huang J, Eskola M, Morris AP, Ford I, Reiner AP, Delgado G, Yen LY, Chen Y-DI, Sandhu R, Li M, Boerwinkle E, Eisele L, Lannfelt L, Rost N, Anderson CD, Taylor KD, Campbell A, Magnusson PK, Porteous D, Hoking LJ, Vlachopoulou E, Pedersen NL, Nikus K, Melander MO, Hamsten A, Heeringa J, Denny JC, Kriebel J, Darbar D, Cheh CN, Shaffer C, Macfarlane PW, Heimbach SH, Almgren P, Huang PL, Sotoodehnia N, Soliman EZ, Uitterlinden AG, Hofman A, Franco OH, Völker U, Jöckel K-H, Sinner MF, Lin HJ, Guo X, Dichgans M, Ingelsson E, Kooperberg C, Melander O, Loos RJF, Laurikka J, Conen D, Rosand J, Harst P van der, Lokki M-L, Kathiresan S, Pereira A, Jukema JW, Hayward C, Rotter JI, März W, Lehtimäki T, Stricker BH, Chung MK, Felix SB, Gudnason V, Alonso A, Roden DM, Kääb S, Chasman DI, Heckbert SR, Benjamin EJ, Tanaka T, Lunetta KL, Lubitz SA, Ellinor PT. Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation [Internet]. Nature Genetics. 2017 ; 49( 6): 946-952.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1038/ng.3843
Artigo de periodico
Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab (2017)
Ridker, Paul M.; Tardif, Jean-Claude; Amarenco, Pierre; Duggan, William; Glynn, Robert J.; Jukema, J. Wouter; Kastelein, John J.P.; Kim, Albert M.; Koenig, Wolfgang; Nissen, Steven; Revkin, James; Rose, Lynda M.; Santos, Raul D.; Schwartz, Pamela F.; Shear, Charles L.; Yunis, Carla
Source: The New England Journal of Medicine. Unidade: FM
Subjects: COLESTEROL, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ANTICORPOS MONOCLONAIS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIDKER, Paul M. et al. Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab. The New England Journal of Medicine, v. 376, n. 16, p. 1517-1526, 2017Tradução . . Disponível em: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614062. Acesso em: 01 nov. 2024.
APA
Ridker, P. M., Tardif, J. -C., Amarenco, P., Duggan, W., Glynn, R. J., Jukema, J. W., et al. (2017). Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab. The New England Journal of Medicine, 376( 16), 1517-1526. doi:10.1056/NEJMoa1614062
NLM
Ridker PM, Tardif J-C, Amarenco P, Duggan W, Glynn RJ, Jukema JW, Kastelein JJP, Kim AM, Koenig W, Nissen S, Revkin J, Rose LM, Santos RD, Schwartz PF, Shear CL, Yunis C. Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1517-1526.[citado 2024 nov. 01 ] Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614062
Vancouver
Ridker PM, Tardif J-C, Amarenco P, Duggan W, Glynn RJ, Jukema JW, Kastelein JJP, Kim AM, Koenig W, Nissen S, Revkin J, Rose LM, Santos RD, Schwartz PF, Shear CL, Yunis C. Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1517-1526.[citado 2024 nov. 01 ] Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614062
Artigo de periodico
Ezetimibe added to statin therapy after acute coronary syndromes (2015)
Cannon, Christopher P.; Blazing, Michael A.; Giugliano, Robert P.; McCagg, Amy; White, Jennifer A.; Theroux, Pierre; Darius, Harald; Lewis, Basil S.; Ophuis, Ton Oude; Jukema, J. Wouter; Ferrari, Gaetano M. De; Ruzyllo, Witold; De Lucca, Paul; Im, KyungAh; Bohula, Erin A.; Reist, Craig; Wiviott, Stephen D.; Tershakovec, Andrew M.; Musline, Thomas A.; Braunwald, Eugene; Califf, Robert M.; Marin Neto, José Antonio; Schmidt, André
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: SÍNDROME CORONARIANA AGUDA, TERAPÊUTICA MÉDICA, COLESTEROL, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANNON, Christopher P. et al. Ezetimibe added to statin therapy after acute coronary syndromes. The New England Journal of Medicine, v. 372, n. 25, p. 2387-2397, 2015Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1410489. Acesso em: 01 nov. 2024.
APA
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., et al. (2015). Ezetimibe added to statin therapy after acute coronary syndromes. The New England Journal of Medicine, 372( 25), 2387-2397. doi:10.1056/NEJMoa1410489
NLM
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, Ferrari GMD, Ruzyllo W, De Lucca P, Im KA, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musline TA, Braunwald E, Califf RM, Marin Neto JA, Schmidt A. Ezetimibe added to statin therapy after acute coronary syndromes [Internet]. The New England Journal of Medicine. 2015 ; 372( 25): 2387-2397.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1056/NEJMoa1410489
Vancouver
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, Ferrari GMD, Ruzyllo W, De Lucca P, Im KA, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musline TA, Braunwald E, Califf RM, Marin Neto JA, Schmidt A. Ezetimibe added to statin therapy after acute coronary syndromes [Internet]. The New England Journal of Medicine. 2015 ; 372( 25): 2387-2397.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1056/NEJMoa1410489
Artigo de periodico
A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2 (2012)
Santos, Raul D.; Waters, David D.; Tarasenko, Lisa; Messig, Michael; Jukema, J. Wouter; Chiang, Cheng-Wen; Ferrieres, Jean; Foody, JoAnne M.
Source: Atherosclerosis. Unidade: FM
Subjects: COLESTEROL (ANÁLISE), CORONARIOPATIA (PATOLOGIA), DISLIPIDEMIAS (ETIOLOGIA), FATORES DE RISCO, LIPOPROTEÍNAS (ANÁLISE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D. et al. A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2. Atherosclerosis, v. 224, n. 1, p. 150-153, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2012.06.052. Acesso em: 01 nov. 2024.
APA
Santos, R. D., Waters, D. D., Tarasenko, L., Messig, M., Jukema, J. W., Chiang, C. -W., et al. (2012). A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2. Atherosclerosis, 224( 1), 150-153. doi:10.1016/j.atherosclerosis.2012.06.052
NLM
Santos RD, Waters DD, Tarasenko L, Messig M, Jukema JW, Chiang C-W, Ferrieres J, Foody JAM. A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2 [Internet]. Atherosclerosis. 2012 ; 224( 1): 150-153.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2012.06.052
Vancouver
Santos RD, Waters DD, Tarasenko L, Messig M, Jukema JW, Chiang C-W, Ferrieres J, Foody JAM. A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2 [Internet]. Atherosclerosis. 2012 ; 224( 1): 150-153.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2012.06.052
Artigo de periodico
Comparison of Lipid Profiles and Attainment of Lipid Goals in Patients <65 Years Versus Patients ≥65 Years (from the Lipid Treatment Assessment Project [L-TAP] 2) (2012)
Rodriguez, Fatima; Santos, Raul D.; Messig, Michael; Tarasenko, Lisa; Ferrières, Jean; Jukema, J. Wouter; Chiang, Cheng-Wen; Waters, David D.; Foody, JoAnne M.
Source: American Journal of Cardiology. Unidade: FM
Subjects: LIPÍDEOS (ANÁLISE), DISLIPIDEMIAS (ETIOLOGIA), ARTERIOSCLEROSE, REGRESSÃO LOGÍSTICA, ANÁLISE MULTIVARIADA, DOENÇAS CARDIOVASCULARES (COMPLICAÇÕES), FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUEZ, Fatima et al. Comparison of Lipid Profiles and Attainment of Lipid Goals in Patients <65 Years Versus Patients ≥65 Years (from the Lipid Treatment Assessment Project [L-TAP] 2). American Journal of Cardiology, v. 109, n. 12, p. 1738-1742, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.amjcard.2012.02.018. Acesso em: 01 nov. 2024.
APA
Rodriguez, F., Santos, R. D., Messig, M., Tarasenko, L., Ferrières, J., Jukema, J. W., et al. (2012). Comparison of Lipid Profiles and Attainment of Lipid Goals in Patients <65 Years Versus Patients ≥65 Years (from the Lipid Treatment Assessment Project [L-TAP] 2). American Journal of Cardiology, 109( 12), 1738-1742. doi:10.1016/j.amjcard.2012.02.018
NLM
Rodriguez F, Santos RD, Messig M, Tarasenko L, Ferrières J, Jukema JW, Chiang C-W, Waters DD, Foody JAM. Comparison of Lipid Profiles and Attainment of Lipid Goals in Patients<65 Years Versus Patients ≥65 Years (from the Lipid Treatment Assessment Project [L-TAP] 2) [Internet]. American Journal of Cardiology. 2012 ; 109( 12): 1738-1742.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.amjcard.2012.02.018
Vancouver
Rodriguez F, Santos RD, Messig M, Tarasenko L, Ferrières J, Jukema JW, Chiang C-W, Waters DD, Foody JAM. Comparison of Lipid Profiles and Attainment of Lipid Goals in Patients<65 Years Versus Patients ≥65 Years (from the Lipid Treatment Assessment Project [L-TAP] 2) [Internet]. American Journal of Cardiology. 2012 ; 109( 12): 1738-1742.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.amjcard.2012.02.018

USP Schools

ReP

Filtros

Authors

Subjects

Source title

Indexado em

Non normalized affiliation

Countries of institutions of collaboration